Method Article

Detection of Drug Susceptibility and Drug Interactions in Mycobacterium tuberculosis using Resazurin Microtiter and Checkerboard Assay

DOI:

10.3791/67672

October 24th, 2025

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Here, we present a protocol to visualize and standardize resazurin microtiter assay (REMA) and its checkerboard variation for evaluating the drug susceptibility and interaction profiles of Mycobacterium tuberculosis. This method provides insights, in vitro, for optimizing drug combinations to be used in treatment regimens and combating multidrug-resistant tuberculosis.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The emergence of multidrug-resistant tuberculosis (MDR-TB) necessitates rapid and accurate drug susceptibility testing (DST) methods to guide effective treatment. This study introduces a methodology combining the resazurin microtiter assay (REMA) and checkerboard assay to determine minimum inhibitory concentration (MIC) and evaluate drug-drug interactions of anti-tuberculosis drugs against Mycobacterium tuberculosis. The REMA, adapted to a 96-well format, leverages the reduction of resazurin dye by metabolically active M. tuberculosis as a visual indicator of drug susceptibility. Varying concentrations of anti-TB drugs are tested against M. tuberculosis isolates, and color changes are observed to determine the MIC. Subsequently, a checkerboard assay is employed to assess potential synergistic, additive, or antagonistic effects between drug combinations. This simple and inexpensive method yields results within seven days, offering a significant advantage over traditional DST methods. This method provides valuable insights into the DST of M. tuberculosis isolates and facilitates the identification of promising drug combinations for improved treatment outcomes against MDR-TB.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a formidable global health challenge, exacerbated by the emergence of drug-resistant strains. According to the World Health Organization (WHO), in 2023, there were an estimated 10.6 million new TB cases and 1.3 million deaths, highlighting the pressing need for more effective diagnostic and therapeutic strategies1. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) pose major challenges to disease control due to the complexity, toxicity, and prolonged duration of current treatment regimens2,3

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

NOTE: Chemicals and materials utilized in the example experiments are available in the Table of Materials file.

1. Preparation of 7H9-S Media

  1. For 100 mL of 7H9-S media, weigh 0.47 g of 7H9 powder and 0.1 g of casitone, then dissolve in 90 mL of distilled water; stir until fully dissolved.
  2. Sterilize the broth in a 250 mL flask using an autoclave at 121 °C for 15 min.
  3. Once autoclaved and cooled, add 10 mL of Oleic Albumin Dextrose Catalase (OADC) supplement and 0.5 mL of glycerol.
  4. Incubate overnight at 37 °C to check for sterility.
    NOTE: The sterility....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Determination of MIC of anti-TB drugs by REMA assay
The activities of Bedaquiline, Delamanid, Moxifloxacin, and Isoniazid were evaluated using REMA against drug-sensitive H37RV and drug-resistant clinical isolate of M. tuberculosis. Bedaquiline, Delamanid, and Isoniazid were used in the concentration range of (1 µg/mL to 0.03 µg/mL) and Moxifloxacin was in the range of (2 µg/mL to 0.06 µg/mL). The bacterial suspensions of drug-resistant clinical isolates of M. tuberculosis and H37Rv.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The global threat posed by drug-resistant tuberculosis (DR-TB) has become a pressing issue1,19. This has created an urgent need for developing improved, rapid methods for drug susceptibility testing (DST), particularly for second-line and newer anti-TB drugs. Such methods are essential to enhance treatment strategies, manage anti-TB drugs effectively, and reduce the risks of disease progression and further resistance20. A method that evalu.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
250 mL square bottle with capSchott Duran218203655Media preparation
7H9 brothBecton Dickinson271310Growth media for M. tuberculosis (Room temparature)
96-well plate with lidCorning359696-well Clear Flat Bottom Polystyrene TC-treated Microplates, Individually Wrapped, with Lid, Sterile (Room temparature)
ART-Tips (1000 μL)TARSONS528106Hydrophobic polyethylene filters with  Polypropylene Racked Filter Tip-Sterile (Room temparature)
ART-Tips (200 μL)TARSONS528104Hydrophobic polyethylene filters with  Polypropylene Racked Filter Tip-Sterile (Room temparature)
Barium chloride dihydrateMerck217565McFarland Standard preparation (Room temparature)
Bedaquiline (BDQ)Jansen and JansenGift from Jansen and JansenAnti-TB drug (4 °C)
CasitoneBecton Dickinson225930Supplement for bacterial culture (Room temparature)
Delamanid (DEL)Otsuka PharmaceuticalsGift from Otsuka PharmaceuticalsAnti-TB drug (4 °C)
Dimethyl sulfoxideSigma-Aldrich67-68-5Drug stock preparation (Room temparature)
Filter 0.2 μmMilliporeSLGVR33RS0.22  μm PVDF ,disposable , sterile syringe filter (Room temparature)
GlycerolMerck356350Added to culture media (Room temparature)
Inoculating LoopSigma-AldrichI8263For culture suspension preparation (Room temparature)
Isoniazid (INH)Sigma-AldrichI3377-5GAnti-TB drug (4 °C)
LJ medium SlantBD Mycobactosel221414Growth media for M. tuberculosis (4 °C)
McCartney Bijou Narrow Mouth bottle, 14 mLSupertek12.124.0014For culture suspension preparation (Room temparature)
McCartney Bijou Narrow Mouth bottle, 7 mLSupertek12.124.0007For culture suspension preparation (Room temparature)
Micropipettes (1000 μL)GilsonF144059MFor precise liquid handling (Room temparature)
Micropipettes (200 μL)GilsonFA10005MFor precise liquid handling (Room temparature)
Moxifloxacin (MOX)Sigma-AldrichSML1581-50MGAnti-TB drug (4 °C)
Multichannel pipette(20–200 μL)VWR849070024For simultaneous pipetting across wells
OADCBecton Dickinson211886Supplement for bacterial culture (4 °C)
Pipette fillersMerckZ333980For precise liquid handling (Room temparature)
Resazurin sodium saltSigma-Aldrich62758-13-8Redox indicator for REMA assays (Room temparature)
Serological pipettes,10 mLCorningCLS4100Sterile, polystyrene disposable pipettes were used (Room temparature)
Solid-glass beads, diam. 6 mmSigma-AldrichZ265950For culture suspension preparation (Room temparature)
Sulfuric acid 95–97%Merck100731McFarland Standard preparation (Room temparature)
Syringes for filterDispo Van100032For use with syringe filters
Vortex MixerREMICM-101 PLUSFor culture suspension preparation
Zipper-top poly bagSigma-AldrichZ162949

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Global tuberculosis report 2023. , World Health Organization. https://www.who.int/publications/i/item/9789240083851 (2023).
  2. Khawbung, J. L., Nath, D., Chakraborty, S. Drug-resistant tuberculosis: A review. Comp Immunol Microbiol Infect Dis. 74, 101574(2021).
  3. Alame Emane, A. K., Guo, X., Takiff, H. E., Liu, S.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Drug SusceptibilityMycobacterium TuberculosisResazurin MicrotiterCheckerboard AssayDrug InteractionsMinimum Inhibitory ConcentrationMultidrug Resistant TuberculosisDrug Susceptibility TestingAnti Tuberculosis DrugsSynergistic Drug Effects
Video Coming Soon

Related Articles